These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 5125053

  • 1. [Use of amantadine in parkinsonism].
    Crudeli R, Candia O.
    Minerva Med; 1971 Oct 31; 62(82):3963-4. PubMed ID: 5125053
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Parkinsonism with amantadine hydrochloride.
    Pa Med; 1971 Apr 31; 74(4):54-5. PubMed ID: 5147644
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. L-dopa and amantadine for Parkinsonism.
    Drug Ther Bull; 1970 Aug 14; 8(17):65-7. PubMed ID: 5480244
    [No Abstract] [Full Text] [Related]

  • 8. [Therapeutic association of amantadine and L-Dopa in parkinsonism].
    Signorelli CD, D'Andrea F, De Divitiis E, Cerillo A.
    Minerva Med; 1971 Oct 31; 62(82):4015-6. PubMed ID: 5125068
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM, Baroni A.
    Minerva Med; 1971 Oct 31; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract] [Full Text] [Related]

  • 12. [Current treatment of Parkinsonism with amantadine hydrochloride].
    Gerstenbrand F, Gründig E, Musiol A.
    Pol Tyg Lek; 1972 Jul 03; 27(23):878-9. PubMed ID: 5040531
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J.
    J Fla Med Assoc; 1970 Jun 03; 57(6):28-33. PubMed ID: 5445813
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa].
    De Divitiis E, D'Andrea F, Signorelli CD, Cerillo A.
    Minerva Med; 1971 Oct 31; 62(82):4007-8. PubMed ID: 5125065
    [No Abstract] [Full Text] [Related]

  • 17. [Amantadine therapy in Parkinsonism].
    Forssman B, Kihlstrand S, Larsson LE.
    Lakartidningen; 1972 Mar 27; 69():55-9. PubMed ID: 4577428
    [No Abstract] [Full Text] [Related]

  • 18. The antiparkinson properties of amantadine in drug-induced parkinsonism.
    Kelly JT, Abuzzahab FS.
    J Clin Pharmacol New Drugs; 1971 Mar 27; 11(3):211-4. PubMed ID: 5211353
    [No Abstract] [Full Text] [Related]

  • 19. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
    Buscaino GA, Campanella G, Zallone E.
    Minerva Med; 1971 Oct 31; 62(82):3974-8. PubMed ID: 5125057
    [No Abstract] [Full Text] [Related]

  • 20. Amantadine in Parkinsonism. An extended prospective trial.
    Rao NS, Pearce J.
    Practitioner; 1971 Feb 31; 206(232):241-5. PubMed ID: 4928964
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.